Login / Signup

Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance.

Thomas EbertStefan D AnkerLuis M RuilopePaola FiorettoVivian A FonsecaGuillermo E UmpierrezAndreas L BirkenfeldRobert LawatscheckCharlie ScottKatja RohwedderEllen Burgessnull null
Published in: Diabetes care (2024)
Insulin resistance was associated with increased cardiovascular (but not kidney) risk and did not modify finerenone efficacy.
Keyphrases
  • insulin resistance
  • type diabetes
  • glycemic control
  • adipose tissue
  • high fat diet
  • metabolic syndrome
  • skeletal muscle
  • polycystic ovary syndrome
  • high fat diet induced